Erratum: MicroRNA-145 inhibits the malignant phenotypes of gastric carcinoma cells via downregulation of fascin 1 expression (Mol Med Rep (2016) 13 (1033‑1039) DOI: 10.3892/mmr.2015.4609);MicroRNA-145 inhibits the malignant phenotypes of gastric carcinoma cells via downregulation of fascin 1 expression

Molecular Medicine Reports

Volumn 13, Issue 1, 2016, Pages 1033-1039

  Xue, Minghui ^a   Zhao, Lunde ^a   Yang, Fang ^b   Li, Zhenjuan ^b   Li, Guangyan ^b  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b The First Affliated Hospital of Xinxiang Medical University   (China)

Author keywords

Fascin 1; Gastric carcinoma; Invasion; MicroRNA 145; Migration; Proliferation

Indexed keywords

FASCIN; FASCIN 1; MICRORNA 145; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; CARRIER PROTEIN; FSCN1 PROTEIN, HUMAN; MESSENGER RNA; MICRORNA; MIRN145 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GASTRIC CANCER CELL LINE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; STOMACH EPITHELIUM; UPREGULATION; BIOSYNTHESIS; CARCINOMA; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

CARCINOMA; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROFILAMENT PROTEINS; MICRORNAS; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 84954289438     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2022.12613     Document Type: Erratum

References (35)

1. Ishiguro H, Kimura M and Takeyama H: Role of microRNAs in gastric cancer. World J Gastroenterol 20: 5694-5699, 2014.
2. Kuo CY, Chao Y and Li CP: Update on treatment of gastric cancer. J Chin Med Assoc 77: 345-353, 2014.
3. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
4. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
5. Baer C, Claus R and Plass C: Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res 73: 473-477, 2013.
6. Xia J, Guo X, Yan J and Deng K: The role of miR-148a in gastric cancer. J Cancer Res Clin Oncol 140: 1451-1460, 2014.
7. Chen L, Xiao H, Wang ZH, Huang Y, Liu ZP, Ren H and Song H: miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A. BMB Rep 47: 39-44, 2014.
8. Feng R, Chen X, Yu Y, Su L, Yu B, Li J, Cai Q, Yan M, Liu B and Zhu Z: miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 298: 50-63, 2010.
9. He XP, Shao Y, Li XL, Xu W, Chen GS, Sun HH, Xu HC, Xu X, Tang D, Zheng XF, et al: Downregulation of miR-145 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth. FEBS J 279: 4201-4212, 2012.
10. Gao P, Xing AY, Zhou GY, Zhang TG, Zhang JP, Gao C, Li H and Shi DB: The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer. Oncogene 32: 491-501, 2013.
11. Kim JG, Kim TO, Bae JH, Shim JW, Kang MJ, Yang K, Ting AH and Yi JM: Epigenetically regulated MIR941 and MIR1247 target gastric cancer cell growth and migration. Epigenetics 9: 1018-1030, 2014.
12. Kim K, Lee HC, Park JL, Kim M, Kim SY, Noh SM, Song KS, Kim JC and Kim YS: Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics 6: 740-751, 2011.
13. Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang Z, Zhu W, Shu Y and Liu P: MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. FEBS Lett 588: 1168-1177, 2014.
14. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N and Akao Y: Decreased expression of microRNA-143 and-145 in human gastric cancers. Oncology 77: 12-21, 2009.
15. Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, Guo X, Wang B, Gang Y, Zhang Y, et al: MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 6: e1000879, 2010.
16. Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J, Chen HY and Sun XF: Clinicopathological significance of microRNA-31,-143 and-145 expression in colorectal cancer. Dis Markers 26: 27-34, 2009.
17. Ni Y, Meng L, Wang L, Dong W, Shen H, Wang G, Liu Q and Du J: MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. Gene 517: 197-204, 2013.
18. Wang Y, Hu C, Cheng J, Chen B, Ke Q, Lv Z, Wu J and Zhou Y: MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling. Biochem Biophys Res Commun 446: 1255-1260, 2014.
19. Rani SB, Rathod SS, Karthik S, Kaur N, Muzumdar D and Shiras AS: MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells. Neuro Oncol 15: 1302-1316, 2013.
20. Zhang H, Pu J, Qi T, Qi M, Yang C, Li S, Huang K, Zheng L and Tong Q: MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha. Oncogene 33: 387-397, 2014.
21. Croce CM and Calin GA: miRNAs, cancer, and stem cell division. Cell 122: 6-7, 2005.
22. Lee HK, Bier A, Cazacu S, Finniss S, Xiang C, Twito H, Poisson LM, Mikkelsen T, Slavin S, Jacoby E, et al: MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. PLoS One 8: e54652, 2013.
23. Feng Y, Zhu J, Ou C, Deng Z, Chen M, Huang W and Li L: MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1. Br J Cancer 110: 2300-2309, 2014.
24. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M and Matsubara H: miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127: 2804-2814, 2010.
25. Speranza MC, Frattini V, Pisati F, Kapetis D, Porrati P, Eoli M, Pellegatta S and Finocchiaro G: NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. Oncotarget 3: 723-734, 2012.
26. Yang S, Huang FK, Huang J, Chen S, Jakoncic J, Leo-Macias A, Diaz-Avalos R, Chen L, Zhang JJ and Huang XY: Molecular mechanism of fascin function in filopodial formation. J Biol Chem 288: 274-284, 2013.
27. Machesky LM and Li A: Fascin: Invasive filopodia promoting metastasis. Commun Integr Biol 3: 263-270, 2010.
28. Yamakita Y, Matsumura F, Lipscomb MW, Chou PC, Werlen G, Burkhardt JK and Yamashiro S: Fascin1 promotes cell migration of mature dendritic cells. J Immunol 186: 2850-2859, 2011.
29. Guo L, Bai H, Zou D, Zou D, Hong T, Liu J, Huang J, He P, Zhou Q and He J: The role of microRNA-133b and its target gene FSCN1 in gastric cancer. J Exp Clin Cancer Res 33: 99, 2014.
30. Tsai WC, Jin JS, Chang WK, Chan DC, Yeh MK, Cherng SC, Lin LF, Sheu LF and Chao YC: Association of cortactin and fascin-1 expression in gastric adenocarcinoma: Correlation with clinicopathological parameters. J Histochem Cytochem 55: 955-962, 2007.
31. Fu H, Wen JF, Hu ZL, Luo GQ and Ren HZ: Knockdown of fascin1 expression suppresses the proliferation and metastasis of gastric cancer cells. Pathology 41: 655-660, 2009.
32. Fu H, Hu Z, Wen J, Wang K and Liu Y: TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways. Acta Biochim Biophys Sin (Shanghai) 41: 648-656, 2009.
33. Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N and Nakagawa M: miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102: 883-891, 2010.
34. Akanuma N, Hoshino I, Akutsu Y, Murakami K, Isozaki Y, Maruyama T, Yusup G, Qin W, Toyozumi T, Takahashi M, et al: MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer 110: 189-198, 2014.
35. Chen MB, Wei MX, Han JY, Wu XY, Li C, Wang J, Shen W and Lu PH: MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer. Cell Signal 26: 102-109, 2014.